319 related articles for article (PubMed ID: 9519489)
1. Young and recent-onset injecting drug users are at higher risk for HIV.
Fennema JS; Van Ameijden EJ; Van Den Hoek A; Coutinho RA
Addiction; 1997 Nov; 92(11):1457-65. PubMed ID: 9519489
[TBL] [Abstract][Full Text] [Related]
2. [Trends in HIV prevalence and risk behaviour among injecting drug users in Rotterdam, I994-2002].
de Boer IM; Op de Coul EL; Beuker RJ; de Zwart O; Al Taqatqa W; van de Laar MJ
Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2325-30. PubMed ID: 15587051
[TBL] [Abstract][Full Text] [Related]
3. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study.
Lindenburg CE; Krol A; Smit C; Buster MC; Coutinho RA; Prins M
AIDS; 2006 Aug; 20(13):1771-5. PubMed ID: 16931942
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
Spittal PM; Craib KJ; Wood E; Laliberté N; Li K; Tyndall MW; O'Shaughnessy MV; Schechter MT
CMAJ; 2002 Apr; 166(7):894-9. PubMed ID: 11949985
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
Maher L; Jalaludin B; Chant KG; Jayasuriya R; Sladden T; Kaldor JM; Sargent PL
Addiction; 2006 Oct; 101(10):1499-508. PubMed ID: 16968352
[TBL] [Abstract][Full Text] [Related]
6. Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003.
Martin M; Vanichseni S; Suntharasamai P; Mock PA; van Griensven F; Pitisuttithum P; Tappero JW; Chiamwongpaet S; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
Int J Drug Policy; 2010 Jul; 21(4):296-301. PubMed ID: 20079620
[TBL] [Abstract][Full Text] [Related]
7. The relative risk of HIV among IDUs not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
AIDS Care; 2009 Aug; 21(8):984-91. PubMed ID: 20024754
[TBL] [Abstract][Full Text] [Related]
8. Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China.
Zhang Y; Shan H; Trizzino J; Ruan Y; Beauchamp G; Mâsse B; Ma J; Gu Y; He Y; Rui B; Wang J; Poundstone K; Jiang Y; Brooks Jackson J; Shao Y
J Infect; 2007 Mar; 54(3):285-90. PubMed ID: 16831464
[TBL] [Abstract][Full Text] [Related]
9. Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.
van den Berg CH; Smit C; Bakker M; Geskus RB; Berkhout B; Jurriaans S; Coutinho RA; Wolthers KC; Prins M
Eur J Epidemiol; 2007; 22(3):183-93. PubMed ID: 17334821
[TBL] [Abstract][Full Text] [Related]
10. Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.
Platt L; Sutton AJ; Vickerman P; Koshkina E; Maximova S; Latishevskaya N; Hickman M; Bonell C; Parry J; Rhodes T
Eur J Public Health; 2009 Aug; 19(4):428-33. PubMed ID: 19349288
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic.
Platt L; Vickerman P; Collumbien M; Hasan S; Lalji N; Mayhew S; Muzaffar R; Andreasen A; Hawkes S
Sex Transm Infect; 2009 Apr; 85 Suppl 2():ii17-22. PubMed ID: 19307346
[TBL] [Abstract][Full Text] [Related]
12. HIV in injecting drug users in Edinburgh: prevalence and correlates.
Davies AG; Dominy NJ; Peters A; Bath GE; Burns SM; Richardson AM
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):399-405. PubMed ID: 7882106
[TBL] [Abstract][Full Text] [Related]
13. Predictors of mortality among injecting and non-injecting HIV-negative drug users in northern Thailand.
Quan VM; Vongchak T; Jittiwutikarn J; Kawichai S; Srirak N; Wiboonnatakul K; Razak MH; Suriyanon V; Celentano DD
Addiction; 2007 Mar; 102(3):441-6. PubMed ID: 17298652
[TBL] [Abstract][Full Text] [Related]
14. [HIV prevalence among injecting drug users in South Limburg, 1994-1998/1999: increasing trend in Heerlen, not in Maastricht].
Beuker RJ; Berns MP; Hoebe CJ; Jansen M; van de Laar MJ
Ned Tijdschr Geneeskd; 2002 Mar; 146(12):567-70. PubMed ID: 11938581
[TBL] [Abstract][Full Text] [Related]
15. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
[TBL] [Abstract][Full Text] [Related]
16. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA
AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience.
Roy E; Boudreau JF; Boivin JF
Drug Alcohol Depend; 2009 Jun; 102(1-3):158-61. PubMed ID: 19251382
[TBL] [Abstract][Full Text] [Related]
18. Background demographics and risk behaviors of injecting drug users in Karachi, Pakistan.
Parviz S; Fatmi Z; Altaf A; McCormick JB; Fischer-Hoch S; Rahbar M; Luby S
Int J Infect Dis; 2006 Sep; 10(5):364-71. PubMed ID: 16793307
[TBL] [Abstract][Full Text] [Related]
19. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT
Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668
[TBL] [Abstract][Full Text] [Related]
20. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.
Smit C; Lindenburg K; Geskus RB; Brinkman K; Coutinho RA; Prins M
Addiction; 2006 Mar; 101(3):433-40. PubMed ID: 16499516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
